Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (21195)	5/19/1998 10:47:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

<Congratulations on making the SI Biotech review:> Wow, a star in our midst!! Way to go Bob. I wonder if the wedding story will be your next published piece?? Greg

To: Henry Niman who wrote (21195)	5/19/1998 10:48:00 PM
From: Machaon	Respond to of 32384

Henry, thanks for pointing it out to me. My only regret, is that they didn't publish one of my jokes, instead. Oh well....... From the SI Biotech review: << "The critical question for all the biotechs remains. If one company comes up with a truly effective cure for most cancers, what are all those other outfits, whose only purpose is developing cancer cures, going to do? >> Interesting comment, seeing that there are about 360 cancer fighting drugs in development. What do you think are the chances for "one" biotech company to come out with a cure for most cancers? Most new drugs are usually considered very effective, if they have a 30% partial success rate, on only one type of cancer. I'm holding a stock, CEGE "Cell Genesys", who takes a sample of a person's T-Cells, modifies them to attack Cancer and AIDS, grows them into the many millions, and then puts them back into the patients body. "If" this stuff works, it would seem to have the possibilities of being a cure-all, since it is based on the very uniqueness of an individual's DNA. Thanks, Bob